☆ 4.7 Article

Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions

JOURNAL OF CLINICAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Lipoprotein(a)-The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation

Sabina Ugovsek et al.

Summary: Increased levels of lipoprotein(a) are associated with coronary artery disease, degenerative aortic stenosis, and heart failure. These levels are determined by genetic variations of the LPA gene encoding the apolipoprotein(a) component of lipoprotein(a). Lipoprotein(a) increases cardiovascular risk through various mechanisms.

BIOMOLECULES (2022)

Add to Collection

Article Hematology

Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study

Na Xu et al.

Summary: This study found that Lp(a) level is an independent predictor for recurrent cardiovascular events in patients with established events, indicating that Lp(a) level might be a valuable biomarker for risk stratification and prognostic assessment in this high-risk population.

THROMBOSIS JOURNAL (2022)

Add to Collection

Review Medical Laboratory Technology

Lipoprotein(a) and Cardiovascular Disease

Pia R. Kamstrup

Summary: This review article presents evidence from large genetic epidemiologic studies supporting a causal role of high lipoprotein(a) concentrations in cardiovascular disease, and discusses measurements of lipoprotein(a) and potential treatment options. Further research is needed to confirm causality and evaluate the clinical benefits of lowering therapies.

CLINICAL CHEMISTRY (2021)

Add to Collection

Review Peripheral Vascular Disease

Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease (MINOCA): a Review of the Present and Preview of the Future

Soheila Talebi et al.

Summary: MINOCA is not uncommon and has multiple potential coronary etiologies. Multimodality imaging is critical for determining underlying etiology and providing appropriate treatment, resulting in better prognosis for patients.

CURRENT ATHEROSCLEROSIS REPORTS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation

Gissette Reyes-Soffer et al.

Summary: Genome-wide association, epidemiological, and clinical studies have shown high Lp(a) to be a causal risk factor for ASCVD, largely determined by genetics. Its link to CVD may be driven by pro-inflammatory effects, particularly its association with oxPL and inflammation. Therapies targeting apo(a) to reduce Lp(a) levels are in clinical trials to assess their impact on cardiovascular outcomes.

PHARMACOLOGICAL RESEARCH (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA)

Giovanni Occhipinti et al.

Summary: This narrative review discusses the downstream diagnostic approaches to MINOCA and emphasizes the possibility of establishing the underlying cause of MINOCA in the vast majority cases. The exclusion of other possible causes for cardiac troponin elevation has notable implications for tailored secondary prevention measures aimed at improving the overall prognosis of AMI.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Myocardial infarction with non-obstructive coronary artery disease

Bertil Lindahl et al.

Summary: MINOCA, a heterogeneous disease entity seen in 5-10% of all patients with myocardial infarction, has received increasing attention in clinical practice. Challenges remain in the diagnosis, investigation, and management of patients with MINOCA, highlighting the need for further research.

EUROINTERVENTION (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Management of myocardial infarction with Nonobstructive Coronary Arteries (MINOCA): a subset of acute coronary syndrome patients

Anthony G. Matta et al.

Summary: MINOCA represents a significant proportion of AMI population (up to 15%) and requires multimodality imaging for diagnosis. Personalized therapeutic approach is needed for the management of MINOCA patients.

REVIEWS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): a position paper from the Dutch ACS working group

T. F. S. Pustjens et al.

NETHERLANDS HEART JOURNAL (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Vera A. Bittner et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Fourth universal definition of myocardial infarction (2018)

Kristian Thygesen et al.

EUROPEAN HEART JOURNAL (2019)

Add to Collection

Article Medical Laboratory Technology

Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries

Marcus Hjort et al.

CLINICAL CHEMISTRY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Coronary Inflammation by Computed Tomography Pericoronary Fat Attenuation in MINOCA and Tako-Tsubo Syndrome

Nicola Gaibazzi et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)

Borja Ibanez et al.

EUROPEAN HEART JOURNAL (2018)

Add to Collection

Review Cell Biology

Lipoprotein(a): A missing culprit in the management of athero-thrombosis?

Gianna Ferretti et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study

Basmah Safdar et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Fourth Universal Definition of Myocardial Infarction (2018)

Kristian Thygesen et al.

CIRCULATION (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

A Test in Context: Lipoprotein(a) Diagnosis, Prognosis, Controversies, and Emerging Therapies

Sotirios Tsimikas

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronary Artery Disease

Jose Tunon et al.

AMERICAN JOURNAL OF CARDIOLOGY (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.